MICHELLE LACKAMP: Open Payments
NPI 1881155190 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 25 payments from 12 companies in 2025. Trend: 2023 $777 · 2024 $424 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $87 |
| ABBVIE INC. | 3 | $67 |
| Saluda Medical Americas, Inc. | 2 | $60 |
| Lilly USA, LLC | 3 | $56 |
| Amgen Inc. | 2 | $42 |
| Abbott Laboratories | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
Products named: UBRELVY, Evoke, MOUNJARO, EVENITY, Wegovy, FREESTYLE LIBRE 3, Ozempic, Kerendia.
Industry payments across KS — which companies pay providers there.
